期刊
CURRENT OPINION IN MICROBIOLOGY
卷 53, 期 -, 页码 26-34出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2020.01.017
关键词
-
类别
资金
- National Institute of Allergy and Infectious Diseases [5R21AI135641]
- National Office of Research Infrastructure Programs at the NIH [5R24OD010998]
- National Science Foundation [DEB] [1911994]
- Morris Animal Foundation [D18ZO-405]
- BBSRC [BB/T011416/1] Funding Source: UKRI
- Division Of Environmental Biology
- Direct For Biological Sciences [1911994] Funding Source: National Science Foundation
Intestinal helminth parasites present major challenges to the welfare of humans and threaten the global food supply. While the discovery of anthelminthic drugs empowered our ability to offset these harms to society, the alarming rise of anthelminthic drug resistance mitigates contemporary efforts to treat and control intestinal helminthic infections. Fortunately, emerging research points to potential opportunities to combat anthelminthic drug resistance by harnessing the gut microbiome as a resource for discovering novel therapeutics and informing responsible drug administration. In this review, we highlight research that demonstrates this potential and provide rationale to support increased investment in efforts to uncover and translationally utilize knowledge about how the gut microbiome mediates intestinal helminthic infection and its outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据